Surgery Partners Inc [SGRY] stock is trading at $33.69, up 17.63%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SGRY shares have gain 16.09% over the last week, with a monthly amount glided 9.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Surgery Partners Inc [NASDAQ: SGRY] stock has seen the most recent analyst activity on June 28, 2024, when Macquarie initiated its Outperform rating and assigned the stock a price target of $31. Previously, Barclays started tracking the stock with Equal Weight rating on March 06, 2024, and set its price target to $35. On November 14, 2023, upgrade upgraded it’s rating to Outperform and revised its price target to $35 on the stock. BofA Securities upgraded its rating to a Buy and increased its price target to $45 on June 02, 2023. Mizuho initiated its recommendation with a Buy and recommended $48 as its price target on May 12, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on April 21, 2023, and assigned it a price target of $43. In a note dated November 23, 2022, RBC Capital Mkts reiterated an Outperform rating on this stock and revised its target price from $58 to $48.
Surgery Partners Inc [SGRY] stock has fluctuated between $22.05 and $37.83 over the past year. Currently, Wall Street analysts expect the stock to reach $47.5 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $33.69 at the most recent close of the market. An investor can expect a potential return of 40.99% based on the average SGRY price forecast.
Analyzing the SGRY fundamentals
Surgery Partners Inc [NASDAQ:SGRY] reported sales of 2.89B for the trailing twelve months, which represents a growth of 14.16%. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.37 points at the first support level, and at 27.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.48, and for the 2nd resistance point, it is at 37.27.
Ratios To Look Out For
For context, Surgery Partners Inc’s Current Ratio is 1.83. In addition, the Quick Ratio stands at 1.69 and the Cash Ratio stands at 0.39. Considering the valuation of this stock, the price to sales ratio is 1.48, the price to book ratio is 2.19.
Transactions by insiders
Recent insider trading involved Burkhalter Danielle, Chief Human Resources Officer, that happened on Jun 12 ’24 when 6000.0 shares were sold. National Group President, Owens Bradley R. completed a deal on May 31 ’24 to sell 6000.0 shares. Meanwhile, Chief Financial Officer Doherty David T sold 721.0 shares on Mar 14 ’24.
